Skip to main content
BLNC
OTC Trade & Services

Balance Labs Reports Going Concern Doubt, Ineffective Controls, and Massive Dilution from Debt Conversion

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
9
Price
$1.55
Mkt Cap
$72.621M
52W Low
$0.15
52W High
$6.04
Market data snapshot near publication time

summarizeSummary

Balance Labs, Inc. filed its 2025 annual report, revealing substantial doubt about its ability to continue as a going concern, ineffective internal controls, and significant shareholder dilution from a debt-to-equity conversion.


check_boxKey Events

  • Going Concern Warning Issued

    Both management and the independent auditor expressed substantial doubt about the company's ability to continue as a going concern due to an accumulated deficit of $37.65 million and a net loss of $31.77 million for 2025.

  • Ineffective Internal Controls Over Financial Reporting

    Management concluded that disclosure controls and procedures were ineffective and identified material weaknesses in internal controls, citing limited resources, lack of an Audit Committee, and inadequate segregation of duties.

  • Massive Share Dilution from Debt-to-Equity Conversion

    The company converted $4.17 million in principal and accrued interest into 16,667,788 shares of common stock at a conversion price of $0.25 per share in November 2025. This resulted in a non-cash loss on settlement of debt of $16.60 million and significantly increased shares outstanding from 21.67 million to 46.85 million, representing over 116% dilution.

  • Minimal Revenue Generation

    Balance Labs generated only $6,000 in advisory revenue for the full year 2025 and approximately $40,000 in Q1 2026, highlighting its limited operational cash flow and ongoing reliance on external capital.


auto_awesomeAnalysis

This 10-K highlights severe financial and operational challenges for Balance Labs. The going concern warning and the disclosure of ineffective internal controls are critical red flags, indicating high risk and potential for future financial misstatements. While the debt-to-equity conversion reduced liabilities, the massive dilution at a a low conversion price (compared to the market price) significantly impacts existing shareholders. The company's minimal revenue generation further underscores its reliance on external financing and the uncertainty of its business plan, particularly its digital asset treasury strategy which is contingent on capital availability. Investors should be highly cautious given these fundamental issues.

At the time of this filing, BLNC was trading at $1.55 on OTC in the Trade & Services sector, with a market capitalization of approximately $72.6M. The 52-week trading range was $0.15 to $6.04. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed BLNC - Latest Insights

BLNC
Apr 10, 2026, 12:39 PM EDT
Filing Type: 10-K
Importance Score:
9
BLNC
Feb 11, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
7